OBJECTIVES: To determine the sufficiency and accuracy of percutaneous core needle renal biopsy in patients with small renal masses (SRMs). METHODS: A retrospective chart review was performed on those patients who had undergone image-guided 18-gauge core renal biopsy of SRMs < or = 4 cm from February 1999 to October 2006. The information obtained included the initial biopsy technique, pathologic findings, and the clinical outcome. RESULTS: A total of 110 renal biopsies were performed for masses < or = 4 cm. The average renal mass size biopsied was 2.7 cm, with a median of 4 cores taken. Of the 110 biopsies, 100 (90.9%) were sufficient for diagnosis and 10 (9.1%) were indeterminate or provided insufficient tissue. Of the 100 diagnostic biopsies, 65% were interpreted as malignant and 35% as benign. There were 8 complications (7.2%), with 2 postprocedural hematomas (1.8%). Thirty-four patients underwent surgical extirpation; the ultimate histopathologic accuracy of biopsy compared with the final surgical pathologic finding was 100% (34/34) in these patients. CONCLUSIONS: Image-guided core needle biopsy is highly accurate in SRMs, and more than one third of these lesions will be benign. With a low complication rate, core biopsy provides a histopathologic diagnosis that aids in decision-making for the growing number of incidentally detected SRMs.
OBJECTIVES: To determine the sufficiency and accuracy of percutaneous core needle renal biopsy in patients with small renal masses (SRMs). METHODS: A retrospective chart review was performed on those patients who had undergone image-guided 18-gauge core renal biopsy of SRMs < or = 4 cm from February 1999 to October 2006. The information obtained included the initial biopsy technique, pathologic findings, and the clinical outcome. RESULTS: A total of 110 renal biopsies were performed for masses < or = 4 cm. The average renal mass size biopsied was 2.7 cm, with a median of 4 cores taken. Of the 110 biopsies, 100 (90.9%) were sufficient for diagnosis and 10 (9.1%) were indeterminate or provided insufficient tissue. Of the 100 diagnostic biopsies, 65% were interpreted as malignant and 35% as benign. There were 8 complications (7.2%), with 2 postprocedural hematomas (1.8%). Thirty-four patients underwent surgical extirpation; the ultimate histopathologic accuracy of biopsy compared with the final surgical pathologic finding was 100% (34/34) in these patients. CONCLUSIONS: Image-guided core needle biopsy is highly accurate in SRMs, and more than one third of these lesions will be benign. With a low complication rate, core biopsy provides a histopathologic diagnosis that aids in decision-making for the growing number of incidentally detected SRMs.
Authors: Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle Journal: Radiology Date: 2010-09 Impact factor: 11.105
Authors: Hiten D Patel; Michael H Johnson; Phillip M Pierorazio; Stephen M Sozio; Ritu Sharma; Emmanuel Iyoha; Eric B Bass; Mohamad E Allaf Journal: J Urol Date: 2016-02-18 Impact factor: 7.450
Authors: Massimo Galia; Domenico Albano; Alberto Bruno; Antonino Agrusa; Giorgio Romano; Giuseppe Di Buono; Francesco Agnello; Giuseppe Salvaggio; Ludovico La Grutta; Massimo Midiri; Roberto Lagalla Journal: Br J Radiol Date: 2017-07-13 Impact factor: 3.039
Authors: Fernando U Kay; Noah E Canvasser; Yin Xi; Daniella F Pinho; Daniel N Costa; Alberto Diaz de Leon; Gaurav Khatri; John R Leyendecker; Takeshi Yokoo; Aaron H Lay; Nicholas Kavoussi; Ersin Koseoglu; Jeffrey A Cadeddu; Ivan Pedrosa Journal: Radiology Date: 2018-02-01 Impact factor: 11.105
Authors: Brett A Johnson; Sandy Kim; Ryan L Steinberg; Alberto Diaz de Leon; Ivan Pedrosa; Jeffrey A Cadeddu Journal: Urol Oncol Date: 2019-09-17 Impact factor: 3.498